Ici 204448

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 534907

CAS#: 121264-04-8

Description: Ici 204448 is a kappa opioid receptor agonist.

Chemical Structure

Ici 204448
CAS# 121264-04-8

Theoretical Analysis

MedKoo Cat#: 534907
Name: Ici 204448
CAS#: 121264-04-8
Chemical Formula: C23H27Cl3N2O4
Exact Mass: 500.1036
Molecular Weight: 501.829
Elemental Analysis: C, 55.05; H, 5.42; Cl, 21.19; N, 5.58; O, 12.75

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Ici 204448; Ici-204448; Ici204448

IUPAC/Chemical Name: Acetic acid, (3-(1-(((3,4-dichlorophenyl)acetyl)methylamino)-2-(1-pyrrolidinyl)ethyl)phenoxy)-, monohydrochloride, (+-)-


InChi Code: InChI=1S/C23H26Cl2N2O4.ClH/c1-26(22(28)12-16-7-8-19(24)20(25)11-16)21(14-27-9-2-3-10-27)17-5-4-6-18(13-17)31-15-23(29)30;/h4-8,11,13,21H,2-3,9-10,12,14-15H2,1H3,(H,29,30);1H

SMILES Code: O=C(O)COC1=CC=CC(C(N(C(CC2=CC=C(Cl)C(Cl)=C2)=O)C)CN3CCCC3)=C1.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 501.829 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Shaw JS, Carroll JA, Alcock P, Main BG. ICI 204448: a kappa-opioid agonist with limited access to the CNS. Br J Pharmacol. 1989 Apr;96(4):986-92. doi: 10.1111/j.1476-5381.1989.tb11911.x. PMID: 2568146; PMCID: PMC1854424.

2: Rawls SM, Ding Z, Gray AM, Cowan A. Peripheral kappa-opioid agonist, ICI 204448, evokes hypothermia in cold-exposed rats. Pharmacology. 2005 May;74(2):79-83. doi: 10.1159/000083704. Epub 2005 Jan 12. PMID: 15687734.

3: Keïta H, Kayser V, Guilbaud G. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur J Pharmacol. 1995 Apr 24;277(2-3):275-80. doi: 10.1016/0014-2999(95)00122-2. PMID: 7493620.

4: Caram-Salas NL, Reyes-García G, Bartoszyk GD, Araiza-Saldaña CI, Ambriz- Tututi M, Rocha-González HI, Arreola-Espino R, Cruz SL, Granados-Soto V. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat. Eur J Pharmacol. 2007 Nov 14;573(1-3):75-83. doi: 10.1016/j.ejphar.2007.06.034. Epub 2007 Jun 29. PMID: 17643411.

5: Barber A, Bartoszyk GD, Greiner HE, Mauler F, Murray RD, Seyfried CA, Simon M, Gottschlich R, Harting J, Lues I. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400. Br J Pharmacol. 1994 Mar;111(3):843-51. doi: 10.1111/j.1476-5381.1994.tb14815.x. PMID: 8019761; PMCID: PMC1910066.

6: Barber A. Mu- and kappa-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin. Eur J Pharmacol. 1993 May 12;236(1):113-20. doi: 10.1016/0014-2999(93)90233-8. PMID: 8391450.

7: Pol O, Sanchez B, Puig MM. Peripheral effects of opioids in a model of intestinal inflammation in mice. Pharmacology. 1996 Dec;53(6):340-50. doi: 10.1159/000139449. PMID: 9032798.

8: Kumar V, Guo D, Cassel JA, Daubert JD, Dehaven RN, Dehaven-Hudkins DL, Gauntner EK, Gottshall SL, Greiner SL, Koblish M, Little PJ, Mansson E, Maycock AL. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1091-5. doi: 10.1016/j.bmcl.2004.12.018. PMID: 15686919.

9: Carey GJ, Bergman J. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. J Pharmacol Exp Ther. 2001 Apr;297(1):215-23. PMID: 11259547.

10: Russell KR, Moore TT, Potter DE. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec;35(5-6):232-7. doi: 10.1054/npep.2001.0883. PMID: 12030807.

11: McIntosh M, Kane K, Parratt J. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur J Pharmacol. 1992 Jan 7;210(1):37-44. doi: 10.1016/0014-2999(92)90649-o. PMID: 1318203.

12: Trigub MM, Bogdanova NG, Kolpakov AA, Bashkatova VG, Sudakov SK. Effect of peripheral opioid receptor agonists on depressive activity of ethanol. Bull Exp Biol Med. 2014 Apr;156(6):778-80. doi: 10.1007/s10517-014-2448-6. Epub 2014 May 3. PMID: 24824695.

13: Sudakov SK, Nazarova GA, Alekseeva EV, Kolpakov AA. Effect of activated peripheral κ-opioid receptors on the action of nicotine and its withdrawal in nicotine-dependent rats. Bull Exp Biol Med. 2014 Mar;156(5):609-11. doi: 10.1007/s10517-014-2406-3. Epub 2014 Mar 25. PMID: 24770739.

14: Sudakov SK, Bogdanova NG. Activation of Peripheral κ-Opioid Receptors Normalizes Caffeine Effects Modified in Nicotine-Dependent Rats during Nicotine Withdrawal. Bull Exp Biol Med. 2016 Oct;161(6):743-745. doi: 10.1007/s10517-016-3499-7. Epub 2016 Oct 26. PMID: 27785643.

15: Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M, et al. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol. 1994 Dec;113(4):1317-27. doi: 10.1111/j.1476-5381.1994.tb17142.x. PMID: 7889287; PMCID: PMC1510549.

16: Nakasone T, Wakuda H, Sugimoto Y, Kamei C. Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice. Immunopharmacol Immunotoxicol. 2017 Oct;39(5):292-295. doi: 10.1080/08923973.2017.1354879. Epub 2017 Jul 26. PMID: 28745076.

17: Alexeeva EV, Nazarova GA, Sudakov SK. Effects of peripheral μ, δ, and Κ-opioid receptor agonists on the levels of anxiety and motor activity of rats. Bull Exp Biol Med. 2012 Sep;153(5):720-1. doi: 10.1007/s10517-012-1809-2. PMID: 23113268.

18: Moore TT, Potter DE. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001 Aug;73(2):167-78. doi: 10.1006/exer.2001.1022. PMID: 11446767.

19: Funez MI, Ferrari LF, Duarte DB, Sachs D, Cunha FQ, Lorenzetti BB, Parada CA, Ferreira SH. Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron. Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19038-43. doi: 10.1073/pnas.0807922105. Epub 2008 Sep 17. PMID: 18799742; PMCID: PMC2614711.

20: Negus SS, O'Connell R, Morrissey E, Cheng K, Rice KC. Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J Pharmacol Exp Ther. 2012 Mar;340(3):501-9. doi: 10.1124/jpet.111.186783. Epub 2011 Nov 29. PMID: 22128346; PMCID: PMC3286312.